PURPOSE: To explore the association between bladder pain syndrome/interstitial cystitis (BPS/IC) and the risk of subsequent healthcare-seeking behavior for common mental disorders in Taiwan using a population-based administrative database. MATERIALS AND METHODS: Both BPS/IC subjects and their age- and sex-matched non-BPS/IC control subjects who had no previous insomnia and mental diseases, including anxiety, depression, were subsequent serviced for these mental disorders by psychiatrists from the recruited date between 2002 and 2010. The risk of outcomes was assessed with Kaplan-Meier curves; and the impact of BPS/IC was estimated with Poisson regression analysis and Cox proportional hazards models. RESULTS: We included 16,185 BPS/IC subjects and 32,370 non-BPS/IC subjects, with a mean age of 46 years and 73.5 % of women. Difference of the prevalence of hypertension, diabetes, chronic kidney disease, and hyperlipidemia between groups was not significant difference. Subjects with BPS/IC had a significant higher incidence rate of anxiety, depression, and insomnia than the matched controls (92.9 vs 38.4, 101.0 vs 42.2, 47.5 vs 23.0; per 10,000 person-year). After adjusting for age, sex, and common comorbidities in multivariable analysis, BPS/IC remained a significant predictor with hazard ratio and 95 % confidence incidence, 2.4 (2.2-2.7), 2.4 (2.2-2.6), and 2.1 (1.8-2.4) for anxiety, depression, and insomnia, respectively. CONCLUSION: Patients with BPS/IC are at risk of development of anxiety, depression, and insomnia. These findings can help guide urologists, urogynecologists, and psychiatrists toward early identification and treatment of psychological complications that may develop in BPS/IC patients.
PURPOSE: To explore the association between bladder pain syndrome/interstitial cystitis (BPS/IC) and the risk of subsequent healthcare-seeking behavior for common mental disorders in Taiwan using a population-based administrative database. MATERIALS AND METHODS: Both BPS/IC subjects and their age- and sex-matched non-BPS/IC control subjects who had no previous insomnia and mental diseases, including anxiety, depression, were subsequent serviced for these mental disorders by psychiatrists from the recruited date between 2002 and 2010. The risk of outcomes was assessed with Kaplan-Meier curves; and the impact of BPS/IC was estimated with Poisson regression analysis and Cox proportional hazards models. RESULTS: We included 16,185 BPS/IC subjects and 32,370 non-BPS/IC subjects, with a mean age of 46 years and 73.5 % of women. Difference of the prevalence of hypertension, diabetes, chronic kidney disease, and hyperlipidemia between groups was not significant difference. Subjects with BPS/IC had a significant higher incidence rate of anxiety, depression, and insomnia than the matched controls (92.9 vs 38.4, 101.0 vs 42.2, 47.5 vs 23.0; per 10,000 person-year). After adjusting for age, sex, and common comorbidities in multivariable analysis, BPS/IC remained a significant predictor with hazard ratio and 95 % confidence incidence, 2.4 (2.2-2.7), 2.4 (2.2-2.6), and 2.1 (1.8-2.4) for anxiety, depression, and insomnia, respectively. CONCLUSION:Patients with BPS/IC are at risk of development of anxiety, depression, and insomnia. These findings can help guide urologists, urogynecologists, and psychiatrists toward early identification and treatment of psychological complications that may develop in BPS/IC patients.
Authors: Joseph M Novi; Stacey Jeronis; Sindhu Srinivas; Radhika Srinivasan; Mark A Morgan; Lily A Arya Journal: J Urol Date: 2005-09 Impact factor: 7.450
Authors: Nancy N Maserejian; Shan Chen; Gretchen R Chiu; Andre B Araujo; Varant Kupelian; Susan A Hall; John B McKinlay Journal: J Urol Date: 2013-07-10 Impact factor: 7.450
Authors: J Curtis Nickel; Dean Tripp; Valerie Teal; Kathleen J Propert; David Burks; Harris E Foster; Philip Hanno; Robert Mayer; Christopher K Payne; Kenneth M Peters; John W Kusek; Leroy M Nyberg Journal: J Urol Date: 2007-05 Impact factor: 7.450
Authors: Gregory Kanter; Katherine A Volpe; Gena C Dunivan; Sara B Cichowski; Peter C Jeppson; Rebecca G Rogers; Yuko M Komesu Journal: Int Urogynecol J Date: 2016-08-31 Impact factor: 2.894
Authors: Lindsey C McKernan; Colin G Walsh; William S Reynolds; Leslie J Crofford; Roger R Dmochowski; David A Williams Journal: Neurourol Urodyn Date: 2017-10-09 Impact factor: 2.696
Authors: Bruce D Naliboff; Alisa J Stephens; H Henry Lai; James W Griffith; J Quentin Clemens; Susan Lutgendorf; Larissa V Rodriguez; Craig Newcomb; Siobhan Sutcliffe; Wensheng Guo; John W Kusek; J Richard Landis Journal: J Urol Date: 2017-05-18 Impact factor: 7.450
Authors: Bethany F Laden; Catherine Bresee; Amanda De Hoedt; Kai B Dallas; April Scharfenberg; Roopali Saxena; Justin F Senechal; Kamil E Barbour; Jayoung Kim; Stephen J Freedland; Jennifer T Anger Journal: Urology Date: 2021-04-23 Impact factor: 2.649
Authors: Lindsey C McKernan; Leslie J Crofford; Ahra Kim; Simon N Vandekar; William S Reynolds; Kathryn A Hansen; Daniel J Clauw; David A Williams Journal: Pain Med Date: 2021-10-08 Impact factor: 3.750
Authors: Lizath M Aguiniga; Timothy J Searl; Afrida Rahman-Enyart; Ryan E Yaggie; Wenbin Yang; Anthony J Schaeffer; David J Klumpp Journal: Am J Physiol Renal Physiol Date: 2020-01-31
Authors: Afrida Rahman-Enyart; Wenbin Yang; Ryan E Yaggie; Bryan A White; Michael Welge; Loretta Auvil; Matthew Berry; Colleen Bushell; John M Rosen; Charles N Rudick; Anthony J Schaeffer; David J Klumpp Journal: Am J Physiol Regul Integr Comp Physiol Date: 2021-07-28 Impact factor: 3.210